Germline pathogenic variants in HIC1 DNA binding domains are associated with familial serrated polyposis syndrome
International Journal of Cancer · 2025
DOI: 10.1002/ijc.35492 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Xavier Domínguez-Rovira und 24 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), CIBEREHD, Hospital Clínic Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Kruppel-Like Transcription Factors, Germ-Line Mutation, Adenomatous Polyposis Coli. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HORIZON EUROPE Framework Programme, STEPUPIORS, COST Action TRANSCOLONCAN, Instituto de Salud Carlos III, 'la Caixa' Foundation Program of Traslational Research in Cancer -IDIBAP.
Abstract (Originalsprache)
Serrated polyposis syndrome (SPS) is characterized by multiple and/or large serrated polyps and increased colorectal cancer (CRC) risk. Germline predisposition to SPS is mostly undetermined. We aimed to identify a new inherited SPS predisposition component by functionally evaluating a candidate gene replicated in two independent SPS cohorts. Exome sequencing was performed in a discovery cohort of 39 patients from 16 SPS families, and validation of relevant results was performed by multi‐gene panel sequencing in 211 independent SPS patients. Considering the discovery and validation cohorts, three predicted pathogenic missense variants were identified in HIC1 (Hypermethylated in cancer 1): c.110C>T (p.Ala37Val), c.1295A>G (p.Gln432Arg), and c.1411G>A (p.Gly471Arg). HIC1 is a tumor suppressor gene which encodes a transcriptional repressor involved in the DNA damage response, and it is commonly silenced in several cancers and serrated polyps. Two cellular models for HIC1 , a CRISPR/Cas9 knockout model and an overexpression model, were produced. In these in vitro models, we assessed DNA damage levels and the SIRT1 regulatory pathway in the presence and absence of the identified variants. Compared to HIC1 wild‐type, models harboring the HIC1 variants identified in SPS patients showed higher p‐H2AX levels (marker of DNA damage) and impaired HIC1 binding to the SIRT1 promoter. Our results indicate that HIC1 genetic variants located in the zinc finger region affected its transcriptional repressor role. We can conclude that HIC1 may be involved in germline predisposition to SPS through an alteration of its repressor capacity and a faulty DNA damage response, as a molecular mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), CIBEREHD, Hospital Clínic Barcelona, Barcelona, Spain.
- Faculty of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.
- Department of Cellular and Molecular Medicine, UC San Diego, La Jolla, California, USA.
- Department of Bioengineering and Moores Cancer Center, UC San Diego, La Jolla, California, USA.
- Department of Pathology, Hospital Clínic Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), CIBEREHD, Faculty of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.
- Galician Public Foundation of Genomic Medicine (FPGMX), Foundation Health Research Institute of Santiago de Compostela, Genomic Medicine Group, University of Santiago de Compostela, Santiago de Compostela, Spain.
ORCID-Profile: Joaquín Cubiella, Laura Valle, Sergi Castellví-Bel
Förderung
- HORIZON EUROPE Framework Programme, STEPUPIORS, COST Action TRANSCOLONCAN
- Instituto de Salud Carlos III
- 'la Caixa' Foundation Program of Traslational Research in Cancer -IDIBAP
- Generalitat de Catalunya (CERCA)
- Fundació la Marató de TV3
- Fundación Científica Asociación Española Contra el Cáncer
- Ministerio de Ciencia e Innovación
- HORIZON EUROPE Framework Programme
Zitieren
APA
Domínguez-Rovira, X., Arnau-Collell, C., Gonfaus-Ortiz, G., Llargués-Sistac, G., Muñoz, J., Llopis, A., Soares de Lima, Y., Herrera-Pariente, C., Moreira, L., Ocaña, T., Díaz-Gay, M., Cuatrecasas, M., Carballal, S., López-Novo, A., Fernàndez, G., Castells, A., Bujanda, L., Capellà, G., Cubiella, J., …, & Castellví-Bel, S. (2025). Germline pathogenic variants in HIC1 DNA binding domains are associated with familial serrated polyposis syndrome. International Journal of Cancer. https://doi.org/10.1002/ijc.35492
Vancouver
Domínguez-Rovira X, Arnau-Collell C, Gonfaus-Ortiz G, Llargués-Sistac G, Muñoz J, Llopis A, et al. Germline pathogenic variants in HIC1 DNA binding domains are associated with familial serrated polyposis syndrome. International Journal of Cancer. 2025. doi:10.1002/ijc.35492
BibTeX
@article{DomnguezRovira2025,
author = {Domínguez-Rovira, Xavier and Arnau-Collell, Coral and Gonfaus-Ortiz, Gemma and Llargués-Sistac, Gemma and Muñoz, Jenifer and Llopis, Ainara and Soares de Lima, Yasmin and Herrera-Pariente, Cristina and Moreira, Leticia and Ocaña, Teresa and Díaz-Gay, Marcos and Cuatrecasas, Miriam and Carballal, Sabela and López-Novo, Anael and Fernàndez, Guerau and Castells, Antoni and Bujanda, Luis and Capellà, Gabriel and Cubiella, Joaquín and Rodríguez-Alcalde, Daniel and Valle, Laura and Balaguer, Francesc and Ruiz-Ponte, Clara and Bonjoch, Laia and Castellví-Bel, Sergi},
title = {Germline pathogenic variants in HIC1 DNA binding domains are associated with familial serrated polyposis syndrome},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.35492}
}
EUVIMED